Impact of PPM1D mutations in patients with myelodysplastic syndrome and deletion of chromosome 5q

Am J Hematol. 2021 Jun 1;96(6):E207-E210. doi: 10.1002/ajh.26162. Epub 2021 Apr 7.

¹ Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
² MLL Munich Leukemia Laboratory, Munich, Germany.
³ Department of Hematology and Cell Therapy, Medical Clinic and Policlinic I, Leipzig University Hospital, Leipzig, Germany.
⁴ Department of Internal Medicine III, University Hospital Medical Center, Ulm, Germany.
⁵ Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
⁶ Department of Human Genetics, Hannover Medical School, Hannover, Germany.
⁷ Department of Hematology and Oncology, Georg-August-Universität-Göttingen, Göttingen, Germany.
⁸ Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Duesseldorf, Germany.
⁹ Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
¹⁰ Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria.
¹¹ Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.

No abstract available

Publication types